Jefferies analysts weighed in on pharma giant Gilead Sciences, Inc. (NASDAQ:GILD) and oncology research firm CytRx Corporation (NASDAQ:CYTR) in light of patent litigation with …
Wall Street analysts weighed in today on beauty products retailer Ulta Salon Cosmetics & Fragrance Inc.(NASDAQ:ULTA) and biotech firm Athersys, Inc.
Jefferies analysts weighed in today on oil pipeline company Energy Transfer Equity LP (NYSE:ETE) and e-commerce giant Amazon.com, Inc.
Analysts are bullish on Chinese e-commerce giant Alibaba Group Holding Ltd (NYSE:BABA) and online retail giant Amazon.com, Inc.
Celgene Corporation (NASDAQ:CELG) announced an ANDA for its drug Abraxane yesterday. Due to the complex circumstances and probable litigation, one analyst predicts a …
Analysts weighed in on tech giant Apple Inc. (NASDAQ:AAPL) and fast casual dining chain Shake Shack Inc (NYSE:SHAK).
Analysts are weighing in on medical test maker GenMark Diagnostics, Inc (NASDAQ:GNMK) and biotech firm PTC Therapeutics, Inc. (NASDAQ:PTCT), as both stocks hit their 52-week …
On the back of disappointing earnings and outlook, Wall Street analysts reduced their price targets on data visualization software maker Tableau Software Inc (NYSE:DATA) and professional networking giant LinkedIn …
Jefferies analysts are weighing in today on electronic payments giant Paypal Holdings Inc (NASDAQ:PYPL) and social media giant Facebook Inc (NASDAQ:FB), after the companies impressed the …
Earnings never cease to draw up excitement among analysts as ratings flood in today following yesterday’s earnings from Facebook Inc (NASDAQ:FB) and eBay …
